SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING IMAGE: RADIONUCLIDE THERAPY AND IMMUNE CHECKPOINT BLOCKADE SYNERGISTICALLY PROLONG SURVIVAL IN A MOUSE MODEL OF PROSTATE CANCER. CREDIT: IMAGE CREATED BY K LUECKERATH, UCLA. Reston, VA–A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to...
